Medical News Today: Certain genetic variants may influence progression of kidney disease

Patients with a kidney disease called focal segmental glomerulosclerosis who have variants in the APOL1 gene may be at a more advanced disease stage at diagnosis, a study finds.

Non-invasive device enables better monitoring of esophageal disease and inflammation

EnteroTrack, LLC and the University of Colorado (CU) have executed an exclusive license agreement that will allow the company to develop and market a novel device to monitor inflammation of the...

Medical News Today: High TV usage linked to increased junk food consumption

Those of us who watch a lot of TV may be more likely to reach for the junk food, finds a new study, which claims this is due to poor knowledge and fatalistic views about nutrition.

Medical News Today: 'Killer T cells' primed to distinguish and destroy shape-shifting HIV, new study

Findings of a new study reveal why attempts to eradicate latent HIV have failed and offer a strategy that could help to form a therapeutic vaccine to eradicate HIV from the body.

Study identifies part of brain key to controlling attention

For the first time, researchers have convincingly identified an ensemble of neurons in the brain that is crucial to focusing attention and ignoring distractions.

Needs of pediatric eosinophilic esophagitis patients may be met by steroid-based treatment

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in...

New Treatment Strategy Allows Lower Doses of Toxic Tuberculosis Drug Without Compromising Potency - 12/30/14

Already known to cut proteins, the enzyme SPPL3 turns out to have additional talents, according to a new study from Johns Hopkins. In its newly discovered role, SPPL3 works without cutting proteins to activate T cells, the immune system’s foot soldiers.